| 网站首页 | 文章中心 | 下载中心 | 图片中心 | 组织机构 | 行业同道 | 学术会议 | 网络课堂 | 企业展台 | 大众健康 | 网络商城 | |论坛 | 旧版 | 博客 | 论坛币换成点数 | 新手指南 | 子宫肌瘤 | 妇科肿瘤站点 | UC-QQ活动专区 | 专业论坛 | 
您现在的位置: 中国妇产科网 >> 文章中心 >> 专业文章 >> 产科 >> 正文 用户登录 新用户注册
专 题 栏 目
最 新 热 门
最 新 推 荐
相 关 文 章
早产儿医学及社会远期预
第3届早产及胎儿医学会议
孕酮对降低宫颈过短孕妇
早产的临床诊断与治疗指
2008.4.18 重庆 妇科内镜
2008.6.6 重庆 第3届早产
抑制早产的药物治疗的循
2007.5.18 重庆 第2届早
2007.5 重庆 第2届早产与
2006.5.26早产和胎儿医学
相 关 栏 目
相 关 广 告
孕酮对降低宫颈过短孕妇早早产发生风险的作用           ★★★
孕酮对降低宫颈过短孕妇早早产发生风险的作用
作者:Fonseca … 文章来源:N Engl J Med, 2008, 358: 1346-1353. 点击数: 更新时间:2008-5-31 15:55:58

孕酮对降低宫颈过短孕妇早早产发生风险的作用

摘要

 

研究背景

随机研究表明对有既往早产史的孕妇使用孕酮可降低其再次妊娠时早产发生率;若孕妇中孕期间宫颈长度过短则可使早早产风险大为增加,目前孕酮是否可降低此风险仍有待研究。

方法

于常规产前检查时以阴道超声测定24,620名孕妇中孕(孕周中位数22w)宫颈长度,取413例(1.7%)宫颈长度<15mm者为研究对象。随机分组以其中250例对象(60.5%)为干预组、其余163例对象(39.5%)为对照组;在孕24~34w时干预组对象每晚给予孕酮200mg、对照组对象则给予安慰剂。主要观察指标为对象之胎儿是否于孕34w前自然娩出(早早产)。

结果

干预组对象早早产率低于观察组(19.2%vs. 34.4%,RR:0.56,95%CI: 0.36~0.86);干预组新生儿死亡率略低,但无统计学意义(8.1%vs. 13.8%,RR:0.59,95%CI: 0.26~1.25,P=0.17)。干预组对象使用孕酮后未发生严重副反应。

结论

孕酮治疗可降低中孕宫颈过短孕妇早早产发生率。(临床试验注册号:NCT00422526)

(以上译文由上海国际妇幼和平医院朱昊平大夫翻译供稿)

Progesterone and the Risk of Preterm Birth among Women with a Short Cervix

Eduardo B. Fonseca, M.D., Ebru Celik, M.D., Mauro Parra, M.D., Mandeep Singh, M.D., and Kypros H. Nicolaides, M.D., for the Fetal Medicine Foundation Second Trimester Screening Group*

BACKGROUND

Previous randomized trials have shown that progesterone administration in women who previously delivered prematurely reduces the risk of recurrent premature delivery. Asymptomatic women found at midgestation to have a short cervix are at greatly increased risk for spontaneous early preterm delivery, and it is unknown whether progesterone reduces this risk in such women.

METHODS

Cervical length was measured by transvaginal ultrasonography at a median of 22 weeks of gestation (range, 20 to 25) in 24,620 pregnant women seen for routine prenatal care. Cervical length was 15 mm or less in 413 of the women (1.7%), and 250 (60.5%) of these 413 women were randomly assigned to receive vaginal progesterone (200 mg each night) or placebo from 24 to 34 weeks of gestation. The primary outcome was spontaneous delivery before 34 weeks.

RESULTS

Spontaneous delivery before 34 weeks of gestation was less frequent in the progesterone group than in the placebo group (19.2% vs. 34.4%; relative risk, 0.56; 95% confidence interval [CI], 0.36 to 0.86). Progesterone was associated with a nonsignificant reduction in neonatal morbidity (8.1% vs. 13.8%; relative risk, 0.59; 95% CI, 0.26 to 1.25; P = 0.17). There were no serious adverse events associated with the use of progesterone.

CONCLUSIONS

In women with a short cervix, treatment with progesterone reduces the rate of spontaneous early preterm delivery. (ClinicalTrials.gov number, NCT00422526.)

 

本站声明:凡从本站转载文章,必须标明来源为“转载自中国妇产科网www.china-obgyn.net

文章录入:gongxm    责任编辑:gongxm 

  • 上一篇文章:

  • 下一篇文章:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)